Terns Financial Statements From 2010 to 2025

Terns Pharmaceuticals Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 203.2 M 363.9 M 138 M Slightly volatile Other Current Liabilities 6.3 M 11.6 M 3.6 M Slightly volatile Total Current Liabilities 11.5 M 15.7 M 6.5 M Slightly volatile Total Stockholder Equity 186 M 345.9 M 121.7 M Slightly volatile Other Liabilities 806.7 K 1.2 M 494.5 K Slightly volatile Property Plant And Equipment Net 1.2 M 1.5 M 690.7 K Slightly volatile Accounts Payable 1.9 M 2.1 M 1.3 M Slightly volatile Cash 94.6 M 161.4 M 84.8 M Pretty Stable Non Current Assets Total 1.5 M 1.8 M 991.1 K Slightly volatile Non Currrent Assets Other 209.9 K 350 K 295.4 K Slightly volatile Other Assets 0.86 0.9 256.9 K Slightly volatile Cash And Short Term Investments 196.8 M 358.2 M 134 M Slightly volatile Common Stock Shares Outstanding 45 M 79.5 M 32.7 M Slightly volatile Liabilities And Stockholders Equity 203.2 M 363.9 M 138 M Slightly volatile Non Current Liabilities Total 4.1 M 2.4 M 9.8 M Slightly volatile Other Current Assets 3 M 3.9 M 2.2 M Slightly volatile Other Stockholder Equity 806 M 767.6 M 190.3 M Slightly volatile Total Liabilities 12.5 M 18.1 M 16 M Slightly volatile Property Plant And Equipment Gross 2.2 M 3.4 M 1.1 M Slightly volatile Total Current Assets 201.6 M 362.1 M 137 M Slightly volatile Capital Stock 8.6 K 9 K 71 M Slightly volatile Net Working Capital 190.2 M 346.5 M 130.6 M Slightly volatile Property Plant Equipment 924 K 870.5 K 552.5 K Slightly volatile Short and Long Term Debt Total 1.3 M 1.3 M 9.2 M Slightly volatile Current Deferred Revenue 1.1 M 1.4 M 957.8 K Slightly volatile Net Receivables 10.2 M 11.4 M 12.5 M Slightly volatile Inventory 2.4 M 2.7 M 2.9 M Slightly volatile Short and Long Term Debt 10.3 M 11.6 M 12.6 M Slightly volatile Short Term Debt 406.6 K 428 K 9.1 M Slightly volatile Common Stock 6.3 K 9 K 3.9 K Slightly volatile Common Stock Total Equity 4 K 4.5 K 4.9 K Slightly volatile Capital Surpluse 416.1 M 468.2 M 510.4 M Slightly volatile Non Current Liabilities Other 1.3 M 1.5 M 1.6 M Slightly volatile
Terns Pharmaceuticals Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Net Interest Income 14 M 13.3 M 2.9 M Slightly volatile Interest Income 14 M 13.3 M 2.9 M Slightly volatile Depreciation And Amortization 456.5 K 335.8 K 237.6 K Slightly volatile Selling General Administrative 21.1 M 31.8 M 11.7 M Slightly volatile Other Operating Expenses 62.5 M 117.9 M 41.8 M Slightly volatile Research Development 48.5 M 70.1 M 29.6 M Slightly volatile Cost Of Revenue 564.5 K 1 M 323.5 K Slightly volatile Total Operating Expenses 69.6 M 101.9 M 41.3 M Slightly volatile Reconciled Depreciation 624.6 K 896 K 320 K Slightly volatile Non Operating Income Net Other 1.6 M 1.8 M 2 M Slightly volatile Selling And Marketing Expenses 704.8 K 792.9 K 864.5 K Slightly volatile
Terns Pharmaceuticals Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 9.8 M 15.6 M 4.6 M Slightly volatile Begin Period Cash Flow 70.1 M 79.9 M 35 M Slightly volatile Depreciation 624.6 K 896 K 320 K Slightly volatile Capital Expenditures 39.9 K 42 K 276.8 K Pretty Stable Total Cash From Financing Activities 108.9 M 164 M 100 M Pretty Stable End Period Cash Flow 94.6 M 161.4 M 84.8 M Pretty Stable Sale Purchase Of Stock 359.1 K 471.5 K 275 K Slightly volatile Cash And Cash Equivalents Changes 76.6 M 86.1 M 93.9 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 143 161 175 Slightly volatile PTB Ratio 1.21 1.2735 11.1315 Very volatile Book Value Per Share 3.18 4.3502 3.4475 Slightly volatile Stock Based Compensation To Revenue 6.52 7.33 7.9934 Slightly volatile Capex To Depreciation 0.0445 0.0469 2.5602 Slightly volatile PB Ratio 1.21 1.2735 11.1315 Very volatile EV To Sales 105 118 128 Slightly volatile Inventory Turnover 0.1 0.12 0.13 Slightly volatile Days Of Inventory On Hand 2.2 K 2.5 K 2.7 K Slightly volatile Payables Turnover 0.25 0.32 0.1856 Slightly volatile Sales General And Administrative To Revenue 15.64 17.59 19.1823 Slightly volatile Research And Ddevelopement To Revenue 25.05 28.18 30.724 Slightly volatile Capex To Revenue 0.27 0.31 0.3337 Slightly volatile Cash Per Share 3.43 4.5048 3.9024 Pretty Stable Days Payables Outstanding 2.2 K 1.2 K 3.5 K Slightly volatile Income Quality 0.92 0.788 0.9266 Slightly volatile Net Debt To EBITDA 1.93 1.5715 3.1302 Slightly volatile Current Ratio 17.07 23.138 29.0314 Slightly volatile Tangible Book Value Per Share 3.18 4.3502 3.4475 Slightly volatile Shareholders Equity Per Share 3.18 4.3502 3.4475 Slightly volatile Debt To Equity 0.0037 0.0039 0.1303 Slightly volatile Capex Per Share 5.0E-4 5.0E-4 0.0108 Pretty Stable Revenue Per Share 0.0317 0.0356 0.0388 Slightly volatile Interest Debt Per Share 0.0161 0.0169 0.3592 Slightly volatile Debt To Assets 0.0035 0.0037 0.0971 Slightly volatile Operating Cycle 2.2 K 2.5 K 2.7 K Slightly volatile Price Book Value Ratio 1.21 1.2735 11.1315 Very volatile Days Of Payables Outstanding 2.2 K 1.2 K 3.5 K Slightly volatile Ebt Per Ebit 1.06 0.8697 0.9777 Pretty Stable Company Equity Multiplier 1.96 1.0522 1.5172 Pretty Stable Long Term Debt To Capitalization 0.0021 0.0024 0.0026 Slightly volatile Total Debt To Capitalization 0.0037 0.0039 0.1098 Slightly volatile Debt Equity Ratio 0.0037 0.0039 0.1303 Slightly volatile Quick Ratio 17.06 23.138 29.0226 Slightly volatile Net Income Per E B T 0.8 1.0029 0.9785 Pretty Stable Cash Ratio 12.79 10.3156 23.262 Slightly volatile Days Of Inventory Outstanding 2.2 K 2.5 K 2.7 K Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.11 1.0006 1.0175 Slightly volatile Price To Book Ratio 1.21 1.2735 11.1315 Very volatile Fixed Asset Turnover 0.77 0.86 0.9384 Slightly volatile Debt Ratio 0.0035 0.0037 0.0971 Slightly volatile Price Sales Ratio 143 161 175 Slightly volatile Asset Turnover 0.0048 0.0054 0.0058 Slightly volatile Gross Profit Margin 0.39 0.44 0.4789 Slightly volatile Price Fair Value 1.21 1.2735 11.1315 Very volatile
Terns Pharmaceuticals Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 430.9 M 506.5 M 425.9 M Pretty Stable Enterprise Value 338 M 322.4 M 335.7 M Slightly volatile

Terns Fundamental Market Drivers

Terns Upcoming Events

About Terns Pharmaceuticals Financial Statements

Pair Trading with Terns Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Terns Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.When determining whether Terns Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Terns Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Terns Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Terns Pharmaceuticals Stock:

How To Invest In Terns Details

Is Terns Stock a good investment? Details

What is Terns Pharmaceuticals' Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details